Bleeding diseases in orthopedic clinical approach

Автор: Yildiz Kadri, Yildiz Vahit

Журнал: Гений ортопедии @geniy-ortopedii

Рубрика: Оригинальные статьи

Статья в выпуске: 2, 2020 года.

Бесплатный доступ

Aim Bleeding diseases are rarely studied as complications of an orthopedic surgical procedure with postsurgical bleeding. This study aims to present a retrospective cohort-study about the approach to bleeding disorders in an ordinary orthopedic clinic. Material and Methods 344 patients were recorded for our study group between November 2017 and September 2019. These patients were monitored for bleeding disorders, both primary or secondary. Results 27 (7.84 %) patients with bleeding diseases [1 (0.29 %) patient with VWD, 1 (0.29 %) patient with hemophilia, 1 (0.29 %) patient with ITP, 15 (4.36 %) patients with drug use, 5 (1.45 %) patients with vascular disorders, 4 (1.16 %) patients with herbal agent use] were detected in all traumatic cases which were admitted to our clinic in this time period . These patients were divided in 6 groups. Patient with VWD was Group 1, patient with hemophilia was Group 2, patient with ITP was Group 3, patients with drug use formed Group 4, patients with vascular disorders - Group 5, patients with herbal agent use - Group 6. Conclusion We advise to have a careful preoperative control for postsurgical bleeding risks according to three criteria: i) patient anamnesis should be studied carefully (diathesis/hemophilia searching), ii) platelet counts must be checked (twice is guaranteed), iii) coagulation tests [activated partial thromboplastin time (aPTT), prothrombin time (PT), thrombin time (TT) and International Normalized Ratio (INR)] must be studied.


Болезнь фон виллебранда (vwd), bleeding diseases/disorders, vwd), itp, drugs, herbal therapy, varicose veins

Короткий адрес:

IDR: 142226221   |   DOI: 10.18019/1028-4427-2020-26-2-191-197

Список литературы Bleeding diseases in orthopedic clinical approach

  • Mansour J., Graf K., Lafferty P. Bleeding disorders in orthopedic surgery. Orthopedics, 2012, vol. 35, no. 12, pp. 1053-1062. DOI: 10.3928/01477447-20121120-09
  • Tara M., Doherty A.K. Bleeding Disorders. Treasure Island (FL), StatPearls Publishing. 2019. ID: NBK541050PMID:. ISBN: 31082094
  • Oberweis B.S., Nukala S., Rosenberg A., Guo Y., Stuchin S., Radford M.J., Berger J.S. Thrombotic and bleeding complications following orthopedic surgery. Am. Heart J., 2013, vol. 165, no. 3, pp. 427-433. E1. DOI: 10.1016/j.ahj.2012.11.005
  • Bolton-Maggs P.H., Chalmers E.A., Collins P.W., Harrison P., Kitchen S., Liesner R.J., Minford A., Mumford A.D., Parapia L.A., Perry D.J., Watson S,P., Wilde J.T., Williams M.D. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br. J. Haematol., 2006, vol. 135, no. 5, pp. 603-633. DOI: 10.1111/j.1365-2141.2006.06343.x
  • Greaves M., Watson H.G. Approach to the diagnosis and management of mild bleeding disorders. J. Thromb. Haemost., 2007, vol. 5, no. Suppl. 1, pp. 167-174. DOI: 10.1111/j.1538-7836.2007.02495.x
  • Kroonen L.T., Gillingham B.L., Provencher M.T. Orthopedic manifestations and management of patients with von Willebrand disease. Orthopedics, 2008, vol. 31, no. 3, pp. 263-269.
  • DOI: 10.3928/01477447-20080301-22
  • Sultan Y., Caen J., Bernard J. Demonstration of recessive transmission in Willebrands diseases. Detection of heterozygotes. C. R. Acad. Hebd. Seances Acad. Sci. D, 1974, vol. 279, no. 13, pp. 1139-1142.
  • Lavin M., O'Donnell J.S. How I treat low von Willebrand factor levels. Blood, 2019, vol. 133, no. 8, pp. 795-804.
  • DOI: 10.1182/blood-2018-10-844936
  • Mansour J., Graf K., Lafferty P. Bleeding disorders in orthopaedic surgery. Orthopaedics, 2012, no. 35(12), pp. 1053-1062.
  • Gopinath R., Sreekanth Y., Yadav M. Approach to bleeding patient. Indian J. Anaesth., 2014, vol. 58, no. 5, pp. 596-602.
  • DOI: 10.4103/0019-5049.144664
  • Diez-Zapirain M.A., Iruin-Irulegui G., Rabanal A., Matorras R. Recurrent Hemoperitoneum after Oocyte Pick-Up in an IVF Patient with Von Willebrand Disease May be Prevented with a Combination of Factor VIII and Von Willebrand Factor. Int. J. Reprod. Med. Gynecol., 2019, vol. 5, no. 1, pp. 001-003.
  • Heijdra J.M., Cnossen M.H., Leebeek F.W.G. Current and Emerging Options for the Management of Inherited von Willebrand Disease. Drugs, 2017, vol. 77, no. 14, pp. 1531-1547.
  • DOI: 10.1007/s40265-017-0793-2
  • Gill J.C., Shapiro A., Valentino L.A., Bernstein J., Friedman C., Nichols W.L., Manco-Johnson M. Von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease. Haemophilia, 2011, vol. 17, no. 6, pp. 895-905.
  • DOI: 10.1111/j.1365-2516.2011.02534.x
  • Higasa S., Tokugawa T., Sawada A. Diagnosis and management of Von Willebrand disease. Rinsho Ketsueki, 2018, vol. 59, no. 10, pp. 2222-2232.
  • DOI: 10.11406/rinketsu.59.2222
  • Keesler D.A., Flood V.H. Current issues in diagnosis and treatment of von Willebrand disease. Res. Pract. Thromb. Haemost., 2017, vol. 2, no. 1, pp. 34-41.
  • DOI: 10.1002/rth2.12064
  • Echahdi H., El Hasbaoui B., El Khorassani M., Agadr A., Khattab M. Von Willebrand's disease: case report and review of literature. Pan Afr. Med. J., 2017, vol. 27, p. 147.
  • DOI: 10.11604/pamj.2017.27.147.12248
  • Turkiz G. Von Willebrand Disease Basic Hemostasis Thrombosis Course Book. Gazi University, Turk Hematology Society. 2007, pp. 52-59.
  • Macfarlane D.E., Stibbe J., Kirby E.P., Zucker M.B., Grant R.A., McPherson J. Letter: A method for assaying von Willebrand factor (ristocetin cofactor). Thromb. Diath. Hemorrh., 1975, vol. 34, no. 1, pp. 306-308.
  • Miller C.H., Graham J.B., Goldin L.R., Elston R.C. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood, 1979, vol. 54, no. 1, pp. 117-136.
  • Simon D., Kunicki T., Nugent D. Platelet function defects. Haemophilia, 2008, vol. 14, no. 6, pp. 1240-1249.
  • DOI: 10.1111/j.1365-2516.2008.01898.x
  • Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B., Chong B.H., Cines D.B., Gernsheimer T.B., Godeau B., Grainger J., Greer I., Hunt B.J., Imbach P.A., Lyons G., McMillan R., Rodeghiero F., Sanz M.A., Tarantino M., Watson S., Young J., Kuter D.J. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 2010, vol. 115, no. 2, pp. 168-186.
  • DOI: 10.1182/blood-2009-06-225565
  • Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D.M., Bussel J.B., Cines D.B., Chong B.H., Cooper N., Godeau B., Lechner K., Mazzucconi M.G., McMillan R., Sanz M.A., Imbach P., Blanchette V., Kühne T., Ruggeri M., George J.N. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 2009, vol. 113, no. 11, pp. 2386-2393.
  • DOI: 10.1182/blood-2008-07-162503
  • Olsson B., Andersson P.-O., Jernås M., Jacobsson S., Carlsson B., Carlsson L.M.S., Wadenvik H. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat. Med., 2003, vol. 9, no. 9, pp. 1123-1124.
  • DOI: 10.1038/nm921
  • Caviglia H., Landro M.E., Galatro G., Candela M., Neme D. Epidemiology of fractures in patients with haemophilia. Injury, 2015, vol. 46, no. 10, pp. 1885-1890.
  • DOI: 10.1016/j.injury.2015.06.034
  • Iosifidis M.I., Ntavlis M., Giannoulis I., Malioufas L., Ioannou A., Giantsis G. Acute thrombotic thrombocytopenic purpura following orthopedic surgery: a case report. Arch. Orthop. Trauma Surg., 2006, vol. 126, no. 5, pp. 335-338.
  • DOI: 10.1007/s00402-005-0014-4
  • Lasne D., Jude B., Susen S. From normal to pathological hemostasis. Can. J. Anaesth., 2006, vol. 53, no. 6 Suppl., pp. S2-S11.
  • DOI: 10.1007/bf03022247
  • Van Dijk K., Fischer K, van der Born J.G., Grobbee D.E., van den Berg H.M. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed. haemophilia, 2005, vol. 11, no. 5, pp. 438-443.
  • DOI: 10.1111/j.1365-2516.2005.01124.x
  • Roosendaal G., Lafeber F.P. Pathogenesis of haemophilic arthropathy. Haemophilia, 2006, vol. 12, no. Suppl. 3, pp. 117-121.
  • DOI: 10.1111/j.1365-2516.2006.01268.x
  • Van den Berg H.M., Fischer K., Mauser-Bunschoten E.P., Beek F.J., Roosendaal G., van der Bom J.G., Nieuwenhuis H.K. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br. J. Haematol., 2001, vol. 112, no. 3, pp. 561-565.
  • DOI: 10.1046/j.1365-2141.2001.02580.x
  • Cattaneo M. Aspirin and Clopidogrel: efficacy, safety, and the issue of drug resistance. Arterioscler. Thromb. Vasc. Biol., 2004, vol. 24, no. 11, pp. 1980-1987.
  • DOI: 10.1161/01.ATV.0000145980.39477.a9
  • Gayle J., Kaye A.D., Kaye A.M., Shah R. Anticoagulants: new ones, mechanisms, and perioperative updates. Anesthesiol. Clin., 2010, vol. 28, no. 4, pp. 667-679.
  • DOI: 10.1016/j.anclin.2010.08.013
  • Horlocker T., Wedel D.J., Rowlingson J.C., Enneking F.K., Kopp S.L., Benzon H.T., Brown D.L., Heit J.A., Mulroy M.F., Rosenquist R.W., Tryba M., Yuan C-S. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third edition). Reg. Anesth. Pain Med., 2010, vol. 35, no. 1, pp. 64-101.
  • DOI: 10.1097/aap.0b013e3181c15c70
  • Ang-Lee M.K., Moss J., Yuan C.S. Herbal medicines and perioperative care. JAMA, 2001, vol. 286, no. 2, pp. 208-216.
  • DOI: 10.1001/jama.286.2.208
  • Lisman T., Porte R.J. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood, 2010, vol. 116, no. 6, pp. 878-885.
  • DOI: 10.1182/blood-2010-02-261891
  • Dagi T.F. The management of postoperative bleeding. Surg. Clin. North Am., 2005, vol. 85, no. 6, pp. 1191-1213-x.
  • DOI: 10.1016/j.suc.2005.10.013
  • Garwood C.L., Gortney J.S., Corbett T.L. Is there a role for fondaparinux in perioperative bridging? Am. J. Health Syst. Pharm., 2011, vol. 68, no. 1, pp. 36-42.
  • DOI: 10.2146/ajhp100133
  • Weitz J.I., Hirsch J., Samama M.M. New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest, 2008, vol. 133, no. 6 Suppl., pp. 234S-256S.
  • DOI: 10.1378/chest.08-0673
  • Levi M.M., Eerenberg E., Löwenberg E., Kamphuisen P.W. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management. Neth. J. Med., 2010, vol. 68, no. 2, pp. 68-76.
  • Dhinsa B., Khan W.S., Tailor H. Management of anticoagulation therapy in the perioperative patient. J. Perioper. Pract., 2011, vol. 21, no. 8, pp. 279-283.
  • DOI: 10.1177/175045891102100804
  • Barg A., Barg K., Wiewiorski M., Schneider S.W., Wimmer M.D., Wirtz D.C., Valderrabano V., Pagenstert G. Total ankle replacement in patients with bleeding disorders. Orthopade, 2015, vol. 44, no. 8, pp. 623-638.
  • DOI: 10.1007/s00132-015-3107-y
  • Zulfikar B., Koc B., Ak G., Dikici F., Karaman İ., Atalar A.C., Bezgal F. Surgery in patients with von Willebrand disease. Blood Coagul. Fibrinolysis, 2016, vol. 27, no. 7, pp. 812-816.
  • DOI: 10.1097/MBC.0000000000000500
  • Spencer S.A., Sorger J. Orthopedic issues in vascular anomalies. Semin. Pediatr. Surg., 2014, vol. 23, no. 4, pp. 227-232.
  • DOI: 10.1053/j.sempedsurg.2014.06.015
  • Kotela I., Żbikowski P., Ambroziak P., Kotela A., Lorkowski J., Stefańska-Windyga E., Wojdasiewicz P., Latawiec F., Windyga J. Orthopedic procedures in patients with congenital coagulation disorders: single center experience. Ortop. Traumatol. Rehabil., 2013, vol. 15, no. 6, pp. 601-616.
  • DOI: 10.5604/15093492.1091516
  • Andersen M.F., Holme P.A., Tjønnfjord G.E. Surgical procedures in patients with severe haemophilia 1997-2014. Tidsskr. Nor. Laegeforen, 2019, vol. 139, no. 8.
  • DOI: 10.4045/tidsskr.18.0592
  • Passeri E.V., Martinelli M., Gatteri V., Pivetti S., Passeri C., Cigolini L., Chiari S., Zenorini A., Gaffurini P., Bernardi S., Poli I., Bissolotti L. Standard and water rehabilitation: An analysis of over 14 years' experience in patients with haemophilia or other clotting factor disorders after orthopaedic surgery. haemophilia, 2019, vol. 25, no. 4, pp. 699-707.
  • DOI: 10.1111/hae.13748
  • Erturan G., Guevel B., Alvand A., Goddard N.J. Over two decades of orthopaedic surgery in patients with inhibitors - Quantifying the complication of bleeding. Haemophilia, 2019, vol. 25, no. 1, pp. 21-32.
  • DOI: 10.1111/hae.13647
Статья научная